Application
Dot blot analysis of GABARAPL2 Antibody (Phospho S39) Phospho-specific Pab on nitrocellulose membrane. 50ng of Phospho-peptide or Non Phospho-peptide per dot were adsorbed. Antibody working concentrations are 0.6ug per ml.| Product Name | GABARAPL2 (Phospho S39) |
|---|---|
| Antibody Type | Primary Antibodies |
| Modification | p-S39 |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | DB |
| DB:1:500 |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Gene Synonyms | FLC3A, GEF2 |
|---|---|
| Alternative Names | GABARAPL2 FLC3A GEF2 Gamma-aminobutyric acid receptor-associated protein-like 2 GABA(A) receptor-associated protein-like 2 Ganglioside expression factor 2 General protein transport factor p16 Golgi-associated ATPase enhancer of 16 kDa MAP1 light ch |
| Molecular Weight(MW) | 13667 Da |
| Function | Involved in intra-Golgi traffic. Modulates intra-Golgi transport through coupling between NSF activity and SNAREs activation. It first stimulates the ATPase activity of NSF which in turn stimulates the association with GOSR1 (By similarity) Involved in autophagy (By similarity) |
| Tissue Specificity | Ubiquitous. Expressed at high levels in the brain, heart, prostate, ovary, spleen and skeletal muscle Expressed at very low levels in lung, thymus and small intestine |
| Cellular Localization | Golgi apparatus (By similarity). Cytoplasmic vesicle, autophagosome |
| Entrez Gene | 11345 |
|---|---|
| Nucleotide Accession | NP_009216.1 |
Application
Dot blot analysis of GABARAPL2 Antibody (Phospho S39) Phospho-specific Pab on nitrocellulose membrane. 50ng of Phospho-peptide or Non Phospho-peptide per dot were adsorbed. Antibody working concentrations are 0.6ug per ml.| Application Notes | DB:1:500 |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by two-step phosphospecific peptide affinity purification. |
